Attorneys for the FTX founder have inquired about possibly administering extended-release ADHD medication to their client, citing his difficulties maintaining focus throughout the trial. In a letter dated Oct. 15, attorneys for Sam Bankman-Fried reached out to New York District…
Related Posts
Fidelity to beef up crypto unit by another 25% with 100 new hires
The Digital Assets division within Fidelity Investments will have around 500 total staff members by the first quarter…
FTX hacker dumps 50,000 ETH, still among top 40 Ether holders
The FTX wallet drainer address has been meticulously swapping assets and using bridges to launder stolen funds.
Ether ETFs will only be a ‘sidekick’ to Bitcoin ETFs — Bloomberg analyst
Inflows from the Ether ETF launch may disappoint compared to the record-breaking inflows generated by the launch of…